Device Trial Radar · NCT01853605
NATRELLE® 410 Full and Moderate Height/Projection Breast Implant Continued Access Post-Approval Study
Last checked: Nov 20, 2026Latest source record: Aug 11, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
3,811
Actual
Start
Apr 2003
Primary completion
Aug 2014
Study completion Aug 2014
Sponsor
- Lead sponsor
- AllerganNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 15, 2013
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Post-approval study of the safety and effectiveness of NATRELLE® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants (Styles 410 FM, FF, MM, or MF) for breast augmentation, reconstruction, or revision
Conditions
- Breast Augmentation
- Breast Reconstruction
- Breast Implant Revision
Interventions
Anatomically shaped silicone gel-filled breast implantsDevice
Surgical implant
Primary outcomes
What the sponsor says the trial is designed to measure.
- Subject Satisfaction With Breast Implants on a 5-Point ScaleTime frame: 5 years
- Investigator Satisfaction With Breast Implants on a 5-Point ScaleTime frame: 5 years
- Local ComplicationsTime frame: 5 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Site not named
Eugene, Oregon
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.